Medtronic, a global leader in healthcare technology, is proud to announce that it has been honored with the 2025 MedTech Breakthrough Award for 'Best Overall Medical Device Solution' for its HealthCast™ intelligent patient monitoring solution. This award recognizes the company’s commitment to empowering clinicians to provide exceptional patient care through groundbreaking technology and insights.

MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market. This year, the HealthCast™ intelligent patient monitoring solution from Medtronic stood out for its approach to advancing the status quo of patient monitoring and simplifying patient management^1,2.

An offering of the Acute Care & Monitoring business of Medtronic, HealthCast™ intelligent patient monitoring is a portfolio of connectivity, interoperability, and remote monitoring solutions. By addressing the limitations of intermittent spot checks, HealthCast™ aims to provide continuous monitoring that may help in the early detection of physiologic decline³, potentially aiding in the reduction of unplanned ICU admissions and supporting improved patient outcomes⁴. The use of continuous multi-parameter monitoring has been associated with positive clinical outcomes, such as decreased mortality⁵ and reduced hospital length of stay⁶. The HealthCast™ portfolio supports healthcare professionals with the tools necessary to make informed clinical decisions, enhancing patient care from hospital to home⁷.

The HealthCast™ portfolio includes:

• HealthCast™ wearables: Extend patient monitoring in hospital and home settings by empowering clinical teams to get ahead of patient decline with valuable insights and automated, personalized trending notifications to support proactive decision-making and support patient discharge decisions⁸. Learn more about BioButton®* multi-parameter wearable. ††
• HealthCast™ remote monitoring: Remotely monitor patients providing continuous, near real-time data, insights, and alarms so staff can visualize patient data, respond quickly, and connect data with the EMR. Learn more about Vital Sync™ remote patient monitoring.
• HealthCast™ services: Providing tailored support, including assistance for delivery, device EMR connectivity, technical training, connection service plans, and customer success. Learn more about HealthCast™ services.

"We are incredibly honored to receive the MedTech Breakthrough Award for HealthCast™ intelligent patient monitoring," said Jason Case, vice president research and development for the Acute Care & Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic. "This recognition highlights our dedication to innovation and our commitment to empowering clinicians with technologies to enhance the quality of care for their patients. HealthCast™ intelligent patient monitoring reflects the Acute Care & Monitoring business's focus on empowering healthcare professionals with world-class technology to personalize patient care, anytime, anywhere."

As part of its mission, Medtronic is committed to reducing disparities in outcomes, expanding access, and helping to protect more patients in more places.

For more information about HealthCast™ intelligent patient monitoring and innovative solutions from Medtronic, please visit Medtronic.com/HealthCast™.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Patient monitoring products should not be used as the sole basis for diagnosis or therapy and are intended only as an adjunct in patient assessment.

 ^®* Third party brands are trademarks of their respective owners.

† The BioButton®* multi-parameter wearable device is not intended for critical care monitoring.

1. Areia C, King E, Ede J, Young L, Tarassenko L, Watkinson P, Vollam S. Experiences of current vital signs monitoring practices and views of wearable monitoring: A qualitative study in patients and nurses. Journal of advanced nursing. 2022 Mar;78(3):810-22.

2. Becking-Verhaar FL, Verweij RPH, de Vries M, Vermeulen H, van Goor H, Huisman-de Waal GJ. Continuous Vital Signs Monitoring with a Wireless Device on a General Ward: A Survey to Explore Nurses’ Experiences in a Post-Implementation Period. International Journal of Environmental Research and Public Health. 2023; 20(10):5794.

3. Vroman H, Mosch D, Eijkenaar F, Naujokat E, Mohr B, Medic G, Swijnenburg M, Tesselaar E, Franken M. Continuous vital sign monitoring in patients after elective abdominal surgery: a retrospective study on clinical outcomes and costs. Journal of Comparative Effectiveness Research. 2023 Feb;12(2):e220176.

4. Eddahchouri Y, Peelen RV, Koeneman M, Touw HRW, van Goor H, Bredie SJH. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. Br J Anaesth. 2022 May;128(5):857-863. https://pubmed.bi.nlm.nih.gov/35282866/

5. Sun L, Joshi M, Khan SN, Ashrafian H, Darzi A. Clinical impact of multi-parameter continuous non-invasive monitoring in hospital wards: a systematic review and meta-analysis. Journal of the Royal Society of Medicine. 2020 Jun;113(6):217-24.

6. Brown H, Terrence J, Vasquez P, Bates DW, Zimlichman E. Continuous monitoring in an inpatient medical-surgical unit: a controlled clinical trial. Am J Med. 2014;127(3):226-32.

7. Breteler MJM, Numan L, Ruurda JP, van Hillegersberg R, van der Horst S, Dohmen DAJ, van Rossum MC, Kalkman CJ. Wireless Remote Home Monitoring of Vital Signs in Patients Discharged Early After Esophagectomy: Observational Feasibility Study. JMIR Perioper Med. 2020 Dec 4;3(2):e21705

8. Weller RS, Foard KL, Harwood TN. Evaluation of a wireless, portable, wearable multi-parameter vital signs monitor in hospitalized neurological and neurosurgical patients. J Clin Monit Comput. 2018;32(5):945–951.

Contacts

Pamela Lee
Public Relations
+1-303-218-8264

Ryan Weispfenning
Investor Relations
+1-763-505-4626